Symptoms of lupus include painful swollen joints, fever, rashes and chest pain ... This included an existing Janssen treatment, STELARA® (ustekinumab), which is approved for the treatment ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ORLANDO -- First-dose reactions to IV ustekinumab (Stelara) may be related to IgE recognition of a carbohydrate ...

Ustekinumab-stba is approved for multiple conditions, showing comparable efficacy and safety to Stelara in clinical trials. The biosimilar will be available in subcutaneous and intravenous forms ...

Yesintek, a Stelara biosimilar, received FDA approval for IBD, plaque psoriasis, and psoriatic arthritis, with a launch expected in late 2025. Clinical trials confirmed Yesintek's equivalence to ...

The FDA has approved Celltrion’s Steqeyma (ustekinumab-stba), a biosimilar to Stelara (ustekinumab), for subcutaneous or intravenous use in adults and pediatric patients with plaque psoriasis and ...

Cigna's (NYSE:CI) pharmacy benefit manager, Evernorth Health Services, announced on Thursday plans to launch a biosimilar to ...